Sentence examples for developing new pharmaceuticals from inspiring English sources

Biotechnology and pharmaceutical companies face constant challenges in the course of developing new pharmaceuticals or other products.

Rational drug design is a method for developing new pharmaceuticals that typically involves the elucidation of fundamental physiological mechanisms.

The high cost and limited success in developing new pharmaceuticals has led to suggestions that a different, broader approach to dealing with dementia is required [7].

The educational activity at CAT aims at stimulating highly qualified professionals in the areas related to poisonous animals and their toxins so they can apply this knowledge to developing new pharmaceuticals and/or agrochemical products using biotechnological processes.

Therefore, the main challenge in developing new pharmaceutical alternatives for brain disease treatment is to deliver beneficial drugs across the BBB, while preventing the passage of potential neurotoxins.

The choice of the appropriate mathematical model when developing new pharmaceutical products or elucidating drug release mechanisms strongly depends on the desired or required predictive ability and accuracy of the model.

The outcomes of university research has an enormous economic and social impact – for every university initiated start-up company developing new pharmaceutical products or new sources of clean energy, as examples, the economy grows by the jobs created within the businesses themselves and then from the jobs created by the suppliers of those businesses.

An improved understanding of lipoproteins, which transport lipids throughout the circulation, is vital for developing new pharmaceutical treatments for lipid abnormalities associated with metabolic syndrome.

In recent years, there has been a global surge in the popularity of herbal/traditional medicine, and currently there is enormous interest in developing new pharmaceutical products from such resources.

Therefore, commercial interest in developing new pharmaceutical compounds [ 6, 7] for these diseases is limited because their treatment needs to be affordable to ensure access by the affected poor population.

As part of a study aimed at developing new pharmaceutical products from natural resources, the purpose of this research was twofold: (1) to fractionate crude extracts from the bark of Mahonia aquifolium and (2) to evaluate the strength of the antimutagenic activity of the separate components against one of the common direct-acting chemical mutagens.